Cancer in Scotland: Action for Change set a target that "by 2005, the maximum wait from urgent referral to treatment for all cancers will be two months"
Melanoma - period of diagnosis: 1 October to 31 December 2006
Area of diagnosis | Number of eligible urgent referrals* | Number treated within 2 months (62 days) of referral | % compliance with 2 month urgent referral to treatment target | Minimum wait (Days) | Maximum wait (Days) | Median wait (Days) | 90th Percentile (Days) |
| | | | | | | |
Scotland | 102 | 89 | 87.3% | 0 | 149 | 25 | 69 |
| | | | | | | |
NOSCAN | 21 | 18 | 85.7% | 0 | 73 | 21 | 69 |
Argyll & Clyde (Highland) | - | - | n/a | n/a | n/a | n/a | n/a |
Grampian | 11 | 9 | 81.8% | 0 | 73 | 29 | 72 |
Highland | 4 | 3 | 75.0% | 0 | 68 | 2 | n/a |
Orkney | - | - | n/a | n/a | n/a | n/a | n/a |
Shetland | - | - | n/a | n/a | n/a | n/a | n/a |
Tayside | 6 | 6 | 100.0% | 7 | 50 | 18 | n/a |
Western Isles | - | - | n/a | n/a | n/a | n/a | n/a |
| | | | | | | |
SCAN | 34 | 32 | 94.1% | 0 | 116 | 16 | 44 |
Borders | 2 | 2 | 100.0% | 14 | 15 | n/a | n/a |
Dumfries & Galloway | 3 | 3 | 100.0% | 0 | 2 | 1 | n/a |
Fife | 9 | 9 | 100.0% | 8 | 49 | 16 | n/a |
Lothian | 20 | 18 | 90.0% | 1 | 116 | 22 | 80 |
| | | | | | | |
WOSCAN | 47 | 39 | 83.0% | 0 | 149 | 30 | 72 |
Argyll & Clyde (Greater Glasgow) | 6 | 6 | 100.0% | 10 | 56 | 26 | n/a |
Ayrshire & Arran | 5 | 4 | 80.0% | 0 | 149 | 0 | n/a |
Forth Valley | 5 | 5 | 100.0% | 0 | 36 | 8 | n/a |
Lanarkshire | 10 | 9 | 90.0% | 0 | 64 | 40 | 64 |
Greater Glasgow | 21 | 15 | 71.4% | 0 | 143 | 36 | 83 |
*Exclusion categories are: died prior to receiving treatment, refused treatment, patient induced non-clinical delay, co-morbidities, clinical reasons and initially referred to another non-cancer speciality.
n/a: Not applicable due to small numbers
Cancer waiting times statistics are subject to a programme of quality improvement focusing on consistency and coverage.
These improvements need to be taken in to account when making comparisons on quarter on quarter performance.